Vanguard Personalized Indexing Management, LLC Krystal Biotech, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 1,538 shares of KRYS stock, worth $283,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,538
Previous 1,374
11.94%
Holding current value
$283,330
Previous $252,000
10.71%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KRYS
# of Institutions
291Shares Held
24.9MCall Options Held
270KPut Options Held
177K-
Black Rock Inc. New York, NY3.95MShares$727 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$525 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$483 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$268 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$182 Million10.7% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.73B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...